Vaccine Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Bavarian Nordic A/S

Invitation: PROSTVAC Wrap up

promising, late-stage vaccine candidate for the treatment of advanced prostate cancer, Bavarian Nordic will be hosting a Q&A session at the ASCO Annual Meeting.

Time: Sunday, May 31st 2009 from 09 AM EDT to 10 AM EDT.

Location: Rosen Centre Hotel, 9840 International Drive, Orlando, Florida

Keywords: Bavarian Nordic GmbH, Biotechnology, Biotechnology Business, Biotechnology Company, Drug Development, Oncology, Prostate Cancer, Prostatic Neoplasms, Therapy, Treatment, Vaccines, Bavarian Nordic A/S.

This article was prepared by Vaccine...

• View Other Issues of Vaccine Weekly
  
• View Other NewsRx Publications